venBio Global Strategic Fund II L.P., 10% Owner at Checkmate Pharmaceuticals, Inc. (CMPI), sold 304,102 shares at $10.38 ($3.2M) on 2022-05-10, disclosed to the SEC on 2022-05-12.
Open-market sale of $3.2M CMPI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.38 | 18,676 | $194K | 6.1% |
| 2 | $10.38 | 18,676 | $194K | 6.1% |
| 3 | $10.38 | 17,700 | $184K | 5.8% |
| 4 | $10.39 | 124,525 | $1.3M | 41.0% |
| 5 | $10.39 | 124,525 | $1.3M | 41.0% |
| Total | $10.39 avg | 304,102 |
| $3.2M |
| 100% |
| Filing → |
| IMPL | BUY | 2021-04-29 | $6.8M | — | Filing → |
| AKRO | SELL | 2020-07-06 | $8.0M | — | Filing → |
| AKRO | SELL | 2020-02-10 | $330K | — | Filing → |